Literature DB >> 35653077

Germline Abnormalities in DNA Methylation and Histone Modification and Associated Cancer Risk.

Jenna A Fernandez1, Mrinal M Patnaik2.   

Abstract

PURPOSE OF REVIEW: Somatic mutations in DNA methyltransferases and other DNA methylation associated genes have been found in a wide variety of cancers. Germline mutations in these genes have been associated with several rare hereditary disorders. Among the described germline/congenital disorders, neurological dysfunction and/or growth abnormalities appear to be a common phenotype. Here, we outline known germline abnormalities and examine the cancer risks associated with these mutations. RECENT
FINDINGS: The increased use and availability of sequencing techniques in the clinical setting has expanded the identification of germline abnormalities involving DNA methylation machinery. This has provided additional cases to study these rare hereditary disorders and their predisposition to cancer. Studying these syndromes may offer an opportunity to better understand the contribution of these genes in cancer development.
© 2022. The Author(s), under exclusive licence to Springer Science+Business Media, LLC, part of Springer Nature.

Entities:  

Keywords:  Cancer predisposition; DNA methylation; Epigenetics; Germline mutation; Hereditary disorders; Histone tail modifications

Mesh:

Year:  2022        PMID: 35653077     DOI: 10.1007/s11899-022-00665-5

Source DB:  PubMed          Journal:  Curr Hematol Malig Rep        ISSN: 1558-8211            Impact factor:   4.213


  93 in total

Review 1.  Genomic DNA methylation: the mark and its mediators.

Authors:  Robert J Klose; Adrian P Bird
Journal:  Trends Biochem Sci       Date:  2006-01-05       Impact factor: 13.807

Review 2.  Linking DNA methylation and histone modification: patterns and paradigms.

Authors:  Howard Cedar; Yehudit Bergman
Journal:  Nat Rev Genet       Date:  2009-05       Impact factor: 53.242

3.  G9a/GLP complexes independently mediate H3K9 and DNA methylation to silence transcription.

Authors:  Makoto Tachibana; Yasuko Matsumura; Mikiko Fukuda; Hiroshi Kimura; Yoichi Shinkai
Journal:  EMBO J       Date:  2008-09-25       Impact factor: 11.598

Review 4.  RNA and the epigenetic regulation of X chromosome inactivation.

Authors:  B Panning; R Jaenisch
Journal:  Cell       Date:  1998-05-01       Impact factor: 41.582

Review 5.  Epigenetic modifications: basic mechanisms and role in cardiovascular disease.

Authors:  Diane E Handy; Rita Castro; Joseph Loscalzo
Journal:  Circulation       Date:  2011-05-17       Impact factor: 29.690

6.  Cytosine methylation prevents binding to DNA of a HeLa cell transcription factor required for optimal expression of the adenovirus major late promoter.

Authors:  F Watt; P L Molloy
Journal:  Genes Dev       Date:  1988-09       Impact factor: 11.361

7.  Structure-based mechanistic insights into DNMT1-mediated maintenance DNA methylation.

Authors:  Jikui Song; Marianna Teplova; Satoko Ishibe-Murakami; Dinshaw J Patel
Journal:  Science       Date:  2012-02-10       Impact factor: 47.728

8.  PRMT5-mediated methylation of histone H4R3 recruits DNMT3A, coupling histone and DNA methylation in gene silencing.

Authors:  Quan Zhao; Gerhard Rank; Yuen T Tan; Haitao Li; Robert L Moritz; Richard J Simpson; Loretta Cerruti; David J Curtis; Dinshaw J Patel; C David Allis; John M Cunningham; Stephen M Jane
Journal:  Nat Struct Mol Biol       Date:  2009-02-22       Impact factor: 15.369

9.  Suv39h-mediated histone H3 lysine 9 methylation directs DNA methylation to major satellite repeats at pericentric heterochromatin.

Authors:  Bernhard Lehnertz; Yoshihide Ueda; Alwin A H A Derijck; Ulrich Braunschweig; Laura Perez-Burgos; Stefan Kubicek; Taiping Chen; En Li; Thomas Jenuwein; Antoine H F M Peters
Journal:  Curr Biol       Date:  2003-07-15       Impact factor: 10.834

Review 10.  The molecular hallmarks of epigenetic control.

Authors:  C David Allis; Thomas Jenuwein
Journal:  Nat Rev Genet       Date:  2016-06-27       Impact factor: 53.242

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.